Federica Saracino

Federica Saracino

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
FAFilomena Amoroso
Filomena Amoroso
EIEduardo Ibello
Eduardo Ibello
FSFederica Saracino
Federica Saracino
FCFederica Cermola
Federica Cermola
GPGiovanna Ponticelli
Giovanna Ponticelli
CDCristina D'Aniello
Cristina D'Aniello
Small molecules that can modulate or stabilize cell–cell interactions are valuable tools for investigating the impact of collective cell behavior on various biological processes such as development/morphogenesis, tissue regeneration and cancer progression. Recently, we showed that budesonide, a glucocorticoid widely used as an anti-asthmatic drug, is a potent regulator of stem cell pluripotency. Here we tested the effect of different budesonide derivatives and identified CHD-030498 as a more effective analogue of budesonide. CHD-030498 was able to prevent stem cell pluripotency exit in different cell-based models, including embryonic stem-to-mesenchymal transition, spontaneous differentiation and 3D gastruloid development, and at lower doses compared to budesonide.

31 October 2025 in The EMBO Journal
Verified
Journal Article
Open access
ACArianna Coppola
Arianna Coppola
FAFilomena Amoroso
Filomena Amoroso
FSFederica Saracino
Federica Saracino
GAGennaro Andolfi
Gennaro Andolfi
ESEdoardo Sozzi
Edoardo Sozzi
Annalisa FicoAnnalisa Fico
Annalisa Fico
The role of long non-coding RNAs (lncRNAs) in early mammalian embryogenesis remains unclear due to the complexity of the regulatory mechanisms involving lncRNAs and the limited availability of embryo samples. Stem cell-based models, such as mouse gastruloids, provide new ways to address these challenges. Here, we investigate the function of ultra-conserved lncRNA T-UCstem1 in mammalian body plan formation. Combining morphological and immunofluorescence imaging analyses with bulk and single-cell transcriptomics, we provide evidence indicating that T-UCstem1 is important for mouse gastruloid development and anteroposterior axis extension. T-UCstem1 depletion in gastruloids results in their aberrant development, with defects in the expression of differentiation markers and persistence of pluripotency gene expression. Our single-cell analyses reveal higher levels of cellular heterogeneity in T-UCstem1 -knockdown gastruloids. The presence of cell populations co-expressing pluripotency and differentiation markers points to an important role of T-UCstem1 in the establishment and maintenance of cell identity. Mechanistically, we show that T-UCstem1 acts in a non-cell-autonomous manner through regulation of the Dickkopf-related protein 1 (DKK1)-dependent WNT pathway. Our study identifies a new role for an ultra-conserved lncRNA in gastruloid development and highlights gastruloids as a model system for studying lncRNAs in early development.

30 May 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
FAFilomena Amoroso
Filomena Amoroso
EIEduardo Ibello
Eduardo Ibello
FSFederica Saracino
Federica Saracino
FCFederica Cermola
Federica Cermola
GPGiovanna Ponticelli
Giovanna Ponticelli
CDCristina D'Aniello
Cristina D'Aniello
Small molecules that can modulate or stabilize cell-cell interactions are valuable tools for investigating the impact of collective cell behavior on various biological processes such as development/morphogenesis, tissue regeneration and cancer progression. Recently, we showed that budesonide, a glucocorticoid widely used as anti-asthmatic drug, is a potent regulator of stem cell pluripotency. Here we tested the effect of different budesonide derivatives and identified CHD-030498 as a more effective analogue of budesonide. CHD-030498 was able to prevent stem cell pluripotency exit in different cell-based models, including embryonic stem-to-mesenchymal transition, spontaneous differentiation and 3D gastruloid development, and at lower doses compared to budesonide.